<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00382903835720</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383572</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:24.058Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835522</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383552</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:24.012Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835799</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PERIPHERAL I.V. CATHETERS, WITH INTEGRATED EXTENSIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383579</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:23.955Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835577</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383557</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:09.554Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835607</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383560</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:09.393Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835539</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383553</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:09.220Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835768</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383576</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:09.203Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835782</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383578</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:08.736Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835515</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383551</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:08.633Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835584</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383558</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:08.590Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835560</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383556</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:08.236Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835775</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383577</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:08.169Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835805</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383580</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:07.527Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835591</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383559</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:07.511Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835737</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383573</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:06.222Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835713</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383571</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:06.067Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741234149</udiDi>
    <basicUdiDi>0801741RSXHPRFHBQ</basicUdiDi>
    <tradeName>EnCor EnCompass</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ENCP10GBT</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:47:17.469Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741234170</udiDi>
    <basicUdiDi>0801741RRESNPEB62</basicUdiDi>
    <tradeName>EnCor EnCompass TriConcave</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ENCP10G</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:47:17.439Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741234118</udiDi>
    <basicUdiDi>0801741RRESNPEB62</basicUdiDi>
    <tradeName>EnCor EnCompass TriConcave</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ENCP12G</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:47:17.415Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741234200</udiDi>
    <basicUdiDi>0801741RXKDSFVU8T</basicUdiDi>
    <tradeName>EnCor EnCompass VISILOC</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ENCP7GVLOC</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:47:17.380Z</lastUpdated>
  </row>
</eudamedExport>